Author:
Xue Lijuan,Liu Keanqi,Yan Caixia,Dun Junling,Xu Yexin,Wu Linlin,Yang Huizhu,Liu Huafang,Xie Lin,Wang Guangji,Liang Yan
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference61 articles.
1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018
2. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects;Hong;Int J Mol Sci,2015
3. From NASH to HCC: current concepts and future challenges;Anstee;Nat Rev Gastroenterol Hepatol,2019
4. Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis;Li;Genet Mol Res,2014
5. Nonalcoholic fatty liver disease (NAFLD). mitochondria as players and targets of therapies?;Di Ciaula;Int J Mol Sci,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献